Antenatal magnesium sulfate treatment and risk of necrotizing enterocolitis in preterm infants born at less than 32 weeks of gestation

Antenatal magnesium sulfate (MgSO(4)) treatment is widely used for fetal neuroprotection in women at risk of preterm delivery. However, some studies have recently suggested that in utero MgSO(4) exposure is associated with an increased risk of necrotizing enterocolitis (NEC). This study aimed to inv...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Ji Young, Hong, Jee Youn, Choi, Yun-Sun, Kim, Yoo-Min, Sung, Ji-Hee, Choi, Suk-Joo, Oh, Soo-young, Roh, Cheong-Rae, Kim, Hye Seon, Sung, Se In, Ahn, So Yoon, Chang, Yun Sil, Park, Won Soon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393352/
https://www.ncbi.nlm.nih.gov/pubmed/32733081
http://dx.doi.org/10.1038/s41598-020-69785-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7393352/
https://www.ncbi.nlm.nih.gov/pubmed/32733081
http://dx.doi.org/10.1038/s41598-020-69785-3

Ejemplares similares